MARKET WIRE NEWS

Cosmos Health Purchases an Additional $500,000 in Ethereum Pursuant to its $300 Million Digital Assets Facility

MWN-AI** Summary

On October 10, 2025, Cosmos Health Inc. (NASDAQ: COSM), a global healthcare group, announced its latest investment in Ethereum, acquiring an additional $500,000 worth, raising its total Ethereum investment to $1.5 million. This purchase aligns with the company's larger digital assets strategy financed by a $300 million facility, indicating its commitment to integrating blockchain technology within the healthcare sector.

Greg Siokas, CEO of Cosmos Health, expressed confidence in this investment strategy, highlighting both the current gains from their Ethereum holdings and the potential for further appreciation as the cryptocurrency sees increased adoption. The company perceives select digital assets like Ethereum as long-term investments that could facilitate secure, decentralized healthcare solutions.

Founded in 2009 and based in Nevada, Cosmos Health operates a diversified healthcare model that includes proprietary pharmaceutical and nutraceutical brands such as Sky Premium Life® and Mediterranation®. The company produces and distributes a wide range of healthcare products, including pharmaceuticals and food supplements, under stringent European regulations through its subsidiary Cana Laboratories S.A.

Additionally, Cosmos Health is venturing into the telehealth industry with its acquisition of ZipDoctor, Inc. Based in Texas, this acquisition is part of the company's broader aim to expand across Europe, Asia, and North America, backed by its robust distribution network.

As Cosmos Health continues to leverage digital assets in its operational strategy, the company's focus also includes research and development in major health issues like obesity, diabetes, and cancer, aided by artificial intelligence. However, potential investors are cautioned regarding the inherent risks in the company's forward-looking statements, urging a careful review of the associated uncertainties. For more information, visit their website and LinkedIn.

MWN-AI** Analysis

Cosmos Health Inc. (NASDAQ: COSM) recently expanded its investment in Ethereum by an additional $500,000, bringing its total Ethereum holdings to $1.5 million. This decision, facilitated through a $300 million digital assets facility, signifies Cosmos Health’s intent to embrace blockchain technology as a strategic avenue for growth within the healthcare sector.

In a landscape increasingly shaped by digital assets, Cosmos Health's strategy reflects a growing trend among companies to diversify their balance sheets with cryptocurrencies. Ethereum, known for its smart contract capabilities and strong developer community, positions itself as a critical asset for businesses aiming to integrate decentralized solutions in sectors such as healthcare. CEO Greg Siokas highlighted that the company is already experiencing gains from its earlier investments in Ethereum, showcasing confidence in the cryptocurrency's potential for future appreciation.

Investors should note that while Cosmos’s investments in Ethereum might yield short-term volatility, the long-term outlook remains positive given the increasing adoption of blockchain technologies, particularly in healthcare. This sector can significantly benefit from Ethereum's smart contract functionalities, enabling secure patient data management and transactions.

However, potential investors should approach this from a diversified risk perspective. The cryptocurrency market can experience abrupt fluctuations influenced by regulatory actions and market sentiment. Therefore, while Cosmos Health’s strategic pivot towards digital assets is commendable, it is essential for investors to balance their portfolios with additional asset classes to mitigate the inherent risks associated with cryptocurrency investments.

Overall, Cosmos Health’s actions indicate a forward-looking perspective and an eagerness to position itself at the nexus of healthcare and digital innovation. Investors who can navigate these complexities might find opportunities in the company’s evolving landscape, provided they stay informed about market trends and regulatory developments.

**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.

Source: GlobeNewswire

CHICAGO, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced that it has purchased an additional $500,000 worth of Ethereum (ETH), bringing its total investment in ETH to $1.5 million.

This acquisition was executed pursuant to Cosmos Health’s previously announced $300 million digital assets facility, which is part of the Company’s broader strategic initiative to diversify its balance sheet and leverage blockchain technology within the healthcare and digital wellness sectors.

Greg Siokas, CEO of Cosmos Health, stated: “We are pleased to continue our Ethereum purchases and reiterate our commitment to fully leveraging our $300 million financing facility. We are already seeing gains from our earlier Ethereum investments, and with increased usage and adoption, we believe there is potential for further appreciation. We view select digital assets such as Ethereum not only as long-term investments, but also as potential enablers of secure, decentralized healthcare solutions.”

About Cosmos Health Inc.

Cosmos Health Inc. (Nasdaq:COSM), incorporated in 2009 in Nevada, is a diversified, vertically integrated global healthcare group. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life®, Mediterranation®, bio-bebe®, C-Sept® and C-Scrub®. Through its subsidiary Cana Laboratories S.A., licensed under European Good Manufacturing Practices (GMP) and certified by the European Medicines Agency (EMA), it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. Cosmos Health also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and OTC medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the UK. Furthermore, the Company has established R&D partnerships targeting major health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of novel patented nutraceuticals, specialized root extracts, proprietary complex generics, and innovative OTC products. Cosmos Health has also entered the telehealth space through the acquisition of ZipDoctor, Inc., based in Texas, USA. With a global distribution platform, the Company is currently expanding throughout Europe, Asia, and North America, and has offices and distribution centers in Thessaloniki and Athens, Greece, and in Harlow, UK. More information is available at www.cosmoshealthinc.com , www.skypremiumlife.com , www.cana.gr , www.zipdoctor.co , www.cloudscreen.gr , as well as LinkedIn and X .

Forward-Looking Statements
With the exception of the historical information contained in this news release, the matters described herein may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Words such as “believes,” “expects,” “anticipates,” “intends,” “projects,” “estimates,” “plans,” and similar expressions, or future or conditional verbs such as “will,” “should,” “would,” “may,” and “could,” generally identify forward-looking statements, although not all forward-looking statements contain these words. These statements involve risks and uncertainties that may individually or materially affect the matters discussed herein for a variety of reasons outside the Company’s control, including, but not limited to: the Company’s ability to raise sufficient financing to implement its business plan; the effectiveness of its digital asset strategies, including accumulation and yield-generating activities; the impact of the war in Ukraine on the Company’s business, operations, and the economy in general; and the Company’s ability to successfully develop and commercialize its proprietary products and technologies. Readers are cautioned not to place undue reliance on these forward-looking statements, as actual results could differ materially from those anticipated. Readers are encouraged to review the risk factors set forth in the Company’s filings with the SEC, which are available at the SEC’s website ( www.sec.gov ). The Company disclaims any obligation to update or revise forward-looking statements, whether as a result of new information, future events, or otherwise

Investor Relations Contact:
BDG Communications
cosm@bdgcommunications.com



Disclaimer

This electronic content is for the purposes of solicitation subscriptions for Market Wire News. Market Wire News expects to generate new advertisement revenue resulting from the distribution of this electronic content. The amount of which is unknown at this time. Market Wire News is not a registered investment adviser or broker-dealer. This electronic content does not provide a professional analysis of a COSM financial position. COSM financial position and all other information regarding the featured Company should be verified directly with COSM. This electronic content is provided as an information service only, and any statements and opinions in this electronic content should not be construed as an offer or solicitation to buy or sell any security. Market Wire News accepts no liability for any loss arising from an investor's reliance on or use of this electronic content. An investment in COSM is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Market Wire News does not own, buy, sell or plans to own, buy, sell, and of COSM shares. This electronic content contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Compensation: Market Wire News and its affiliates has received six thousand dollars for Market Wire News advertising services from Relqo Media LLC for Brand Awareness Distribution, Corporate Communications, News, Press Release Enhancement and Social Media Solutions starting 2026-05-31 and ending 2026-06-05 provided by Market Wire News. To date, we have received a total of six thousand dollars. Please read our full disclaimer for compensation and more detailed information.

FAQ**

How does Cosmos Holdings Inc. (COSM) plan to utilize its $300 million digital assets facility to maximize its investments in Ethereum and other digital assets within the healthcare sector?
Cosmos Holdings Inc. plans to utilize its $300 million digital assets facility by strategically investing in Ethereum and other digital assets to enhance its healthcare sector initiatives, drive innovation, and accelerate growth through blockchain technology integration.
What specific gains has Cosmos Holdings Inc. (COSM) experienced from its earlier Ethereum investments, and how do these gains influence its strategy for future digital asset acquisitions?
Cosmos Holdings Inc. has realized significant gains from its early Ethereum investments, which have emboldened its strategy to pursue further digital asset acquisitions by leveraging established success to enhance its portfolio and capitalize on growth in the blockchain sector.
Can you elaborate on how Cosmos Holdings Inc. (COSM) intends to leverage blockchain technology to enhance decentralized healthcare solutions and improve patient outcomes?
Cosmos Holdings Inc. (COSM) aims to leverage blockchain technology by creating a decentralized healthcare ecosystem that ensures secure patient data sharing, enhances supply chain transparency, and facilitates better access to personalized treatment, ultimately improving patient outcomes.
Given the potential risks mentioned, how does Cosmos Holdings Inc. (COSM) plan to mitigate uncertainties related to its digital asset strategies and overall business operations?
Cosmos Holdings Inc. (COSM) aims to mitigate uncertainties related to its digital asset strategies and overall business operations by implementing robust risk management protocols, diversifying its asset portfolio, and continuously adapting to market regulatory changes.

**MWN-AI FAQ is based on asking OpenAI questions about Cosmos Health Inc. (NASDAQ: COSM).

Cosmos Health Inc.

NASDAQ: COSM

COSM Trading

10.1% G/L:

$0.2758 Last:

1,618,807 Volume:

$0.2525 Open:

COSM Ad 300

COSM Latest News

COSM Stock Data

$15,496,877
28,036,959
21.86%
6
N/A
Medical Distributors
Healthcare
US
Thessaloniki

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App